Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/29/2000CA2351674A1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
06/29/2000CA2321143A1 9-aminoacridine derivatives and process for the preparation thereof
06/29/2000CA2293081A1 Restenosis drug therapy
06/28/2000EP1013777A1 Powdered dextrose and method for preparing same
06/28/2000EP1013757A2 Attenuated forms of bovine viral diarrhea virus
06/28/2000EP1013661A1 Novel bicyclonucleoside and oligonucleotide analogues
06/28/2000EP1013660A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these
06/28/2000EP1013647A2 Process for the preparation of N-(amino-4,6-dihalogenopyrimidin)-formamides
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1013289A1 Partricin derivatives in the prophylactic and/or curative treatment of fungal contamination of cell cultures and of tissues
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013281A1 hCG therapy for the treatment of breast cancer
06/28/2000EP1013277A1 Freeze-dried preparations and process for producing the same
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1013275A2 Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/28/2000EP1013274A2 Composition comprising amoxycillin and clavulanic acid
06/28/2000EP1013273A1 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
06/28/2000EP1013272A1 Manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals
06/28/2000EP1013270A2 Controlled release growth hormone containing microspheres
06/28/2000EP1013258A2 Amphipatic lipid dispersion
06/28/2000EP1013178A1 Petroselinic acid and its use in food, fat compositions containing petroselinic acid
06/28/2000EP1013175A1 Sugarfree candied product
06/28/2000EP1012331A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
06/28/2000EP1012302A1 Human nucleotide pyrophosphohydrolase
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012277A2 Syndecan interacting proteins and the use thereof
06/28/2000EP1012267A2 An antisense oligonucleotide preparation method
06/28/2000EP1012262A1 Human frezzled-like protein
06/28/2000EP1012188A1 Composition for treating diabetes mellitus and obesity
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1012180A2 Hepatitis c inhibitor peptide analogues
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1012164A1 Serine protease inhibitors
06/28/2000EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
06/28/2000EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
06/28/2000EP1012158A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
06/28/2000EP1012155A1 Human uncoupling protein 3
06/28/2000EP1012154A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
06/28/2000EP1012151A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
06/28/2000EP1012147A2 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
06/28/2000EP1012146A1 Hiv nuclear localization inhibitors
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1012142A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
06/28/2000EP1012140A1 New amidino derivatives and their use as thrombin inhibitors
06/28/2000EP1012139A1 AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS
06/28/2000EP1012137A1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists
06/28/2000EP1012136A1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists
06/28/2000EP1011743A1 Loading and release of water-insoluble drugs
06/28/2000EP1011737A2 Method for treating proliferative diseases by therapy
06/28/2000EP1011728A1 Prostaglandin product
06/28/2000EP1011726A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011723A1 88kda tumorigenic growth factor and antagonists
06/28/2000EP1011722A1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
06/28/2000EP1011710A1 Methods and compositions for optimization of oxygen transport by cell-free systems
06/28/2000EP1011698A1 Chemical supplementation of bone
06/28/2000EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders
06/28/2000EP1011692A1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY
06/28/2000EP1011691A1 Burn treatment composition
06/28/2000EP1011689A1 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011688A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
06/28/2000EP1011687A1 13-deoxyanthracycline derivatives and processes for preparing them
06/28/2000EP1011686A1 Modulation of human mast cell activation
06/28/2000EP1011684A2 Solid oral dosage form comprising a combination of metformin and glibenclamide
06/28/2000EP1011683A1 Vitamin d analogues and their neuronal effects
06/28/2000EP1011682A2 Hormonal contraceptive
06/28/2000EP1011681A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
06/28/2000EP1011680A2 Controlled release microsphere delivery system
06/28/2000EP1011679A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
06/28/2000EP1011678A1 Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
06/28/2000EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
06/28/2000EP1011676A1 Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage
06/28/2000EP1011675A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea
06/28/2000EP1011674A1 Transdermal therapeutic system containing the active substance scopolamine base
06/28/2000EP1011673A1 Novel niddm regimen
06/28/2000EP1011672A1 Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
06/28/2000EP1011671A1 Substance dependence treatment using opiate antagonists and serotonin compounds
06/28/2000EP1011670A1 Method for treatment of non-rheumatoid athritis
06/28/2000EP1011669A1 Inhibitors of farnesyl-protein transferase
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP1011666A1 Antithrombotic agents
06/28/2000EP1011665A1 Heterocyclic agents
06/28/2000EP1011664A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000EP1011662A1 Improved compositions and methods for the control of smoking
06/28/2000EP1011661A1 Mediation of circadian rhythms
06/28/2000EP1011660A1 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
06/28/2000EP1011659A2 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid
06/28/2000EP1011658A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
06/28/2000EP1011657A1 Nitric oxide inhibits rhinovirus infection
06/28/2000EP1011656A2 A method for treating tension-type headache
06/28/2000EP1011655A1 Inhibitors of leaderless protein export
06/28/2000EP1011654A1 A method of modulating cellular activity
06/28/2000EP1011653A1 Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
06/28/2000EP1011651A1 Method of treating diabetes and related disease states
06/28/2000EP1011649A2 Use of endipalene in the treatment of psoriasis
06/28/2000EP1011648A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
06/28/2000EP1011647A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
06/28/2000EP1011644A1 Methods and apparatus for treatment of parkinson's disease
1 ... 6292 6293 6294 6295 6296 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 ... 7860